Literature DB >> 26049172

Nerve conduction studies in diabetics presymptomatic and symptomatic for diabetic polyneuropathy.

Rainha J de Souza1, Aaron de Souza2, Meera D Nagvekar1.   

Abstract

OBJECTIVE: We performed nerve conduction studies (NCS) on diabetics with and without symptoms of diabetic polyneuropathy (DPN) and evaluated correlations with glycaemic control and clinical features.
METHODS: Consecutive patients were recruited in three groups: "normals" (nondiabetics without peripheral nerve disease); "presymptomatic diabetics" (diabetes without DPN); and "symptomatic diabetics". Clinical questionnaire and neurological examination were administered, and NCS were performed using standard techniques.
RESULTS: 153 patients were recruited (51 normals, 50 presymptomatic diabetics, 52 symptomatic). Glycosylated haemoglobin and duration of DM were higher in symptomatic diabetics, with symptoms present for 1-60 months (mean 14.5). Alterations in NCS included prolonged latencies, lowered amplitudes and slowed conduction velocities, following a pattern of initially reduced sensory amplitudes and slowed motor velocities, with later reduced motor and sensory amplitudes and prolonged motor latencies. Neuropathic pain, clinical signs and glycosylated haemoglobin correlated with these changes.
CONCLUSIONS: Even in asymptomatic patients, NCS show diffuse changes, in a predictable pattern. Electrophysiological parameters correlate with neuropathic pain, physical findings and glycosylated haemoglobin levels. SIGNIFICANCE: We demonstrate that NCS changes in DPN follow a predictable pattern, correlating with clinical features and long-term glycaemic control.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Diabetic polyneuropathy; Electrophysiology; Glycosylated haemoglobin; Nerve conduction studies

Mesh:

Substances:

Year:  2015        PMID: 26049172     DOI: 10.1016/j.jdiacomp.2015.05.009

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  7 in total

1.  Risk factors associated with the progression of overactive bladder among patients with type 2 diabetes.

Authors:  Yiyi Zhu; Zaisheng Zhu; Jiajun Chen
Journal:  Int J Clin Pract       Date:  2019-08-09       Impact factor: 2.503

2.  Performance analysis of noninvasive electrophysiological methods for the assessment of diabetic sensorimotor polyneuropathy in clinical research: a systematic review and meta-analysis with trial sequential analysis.

Authors:  Fahmida Haque; Mamun Bin Ibne Reaz; Sawal Hamid Md Ali; Norhana Arsad; Muhammad Enamul Hoque Chowdhury
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

Review 3.  Glycated Hemoglobin (HbA1c) as a Biomarker for Diabetic Foot Peripheral Neuropathy.

Authors:  Giulia Casadei; Marta Filippini; Lorenzo Brognara
Journal:  Diseases       Date:  2021-02-22

4.  The Evaluation of Gait and Balance for Patients with Early Diabetic Peripheral Neuropathy: A Cross-Sectional Study.

Authors:  Xiaoyan Jiang; Fang Deng; Shunli Rui; Yu Ma; Min Wang; Bo Deng; Hongyan Wang; Chenzhen Du; Bing Chen; Xiuhua Yang; Johnson Boey; David G Armstrong; Wuquan Deng; Xiaodong Duan
Journal:  Risk Manag Healthc Policy       Date:  2022-03-30

5.  Performance Analysis of Conventional Machine Learning Algorithms for Diabetic Sensorimotor Polyneuropathy Severity Classification Using Nerve Conduction Studies.

Authors:  Fahmida Haque; Mamun B I Reaz; Muhammad E H Chowdhury; Serkan Kiranyaz; Sawal H M Ali; Mohammed Alhatou; Rumana Habib; Ahmad A A Bakar; Norhana Arsad; Geetika Srivastava
Journal:  Comput Intell Neurosci       Date:  2022-04-25

6.  Association of serum calprotectin with peripheral neuropathy in patients with type 2 diabetes mellitus.

Authors:  Ramanathan Velayutham; Pradeep Pankajakshan Nair; Prashant S Adole; Vadivelan Mehalingam
Journal:  J Family Med Prim Care       Date:  2021-04-29

7.  Diabetic Distal Symmetrical Polyneuropathy: Correlation of Clinical, Laboratory, and Electrophysiologic Studies in Patients with Type 2 Diabetes Mellitus.

Authors:  Yi-Ching Weng; Sung-Sheng Tsai; Rong-Kuo Lyu; Chun-Che Chu; Long-Sun Ro; Ming-Feng Liao; Hong-Shiu Chang; Chiung-Mei Chen; Jawl-Shan Hwang; Hung-Chou Kuo
Journal:  J Diabetes Res       Date:  2020-07-03       Impact factor: 4.011

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.